Healthcare -
Biotechnology - NASDAQ - US
$ 34.055
1.23 %
$ 14.8 B
Market Cap
17.83
P/E
RPRX - ACCOUNTS PAYABLE
Accounts Payable RPRX - Royalty Pharma plc
13.4 M
LAST VALUE
30.04%
2 YEAR CAGR
3.65%
5 YEAR CAGR
0.00%
10 YEAR CAGR